<DOC>
	<DOCNO>NCT02071654</DOCNO>
	<brief_summary>A prospective , non-randomized , multi-center clinical study Venus P-valve treatment RVOT stenosis pulmonary regurgitation surgery congenital heart defect .</brief_summary>
	<brief_title>Efficacy Safety Venus P-valve Treat RVOT Stenosis With Pulmonary Regurgitation</brief_title>
	<detailed_description>The aim protocol ass efficacy , safety performance Venus P-valve . Patients 18-60 year RVOT stenosis moderate severe pulmonary regurgitation ( ≥3+ ) undergo trans-annular patch repair RVOT , cardiac magnetic resonance ( CMR ) screen right ventricular end-diastolic volume index ( RVEDVI ) 130-160mL/m2 . Post-procedure follow-up schedule 24 hour , 30 day , 6 month 12 month .</detailed_description>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Pulmonary Valve Insufficiency</mesh_term>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<criteria>RVOT stenosis undergone transannular patch repair moderate severe pulmonary regurgitation Isotopic CMR criterion RVEDVI≥130mL/m2 ≤160mL/m2 Age≥18 year ≤60 year ( Zhongshan Hospital age≥18 year ≤60 year Body weight≥18 kg Pulmonary annular diameter 14mm 31mm RVOT length≥20mm The subject his/her legal representative provide write informed consent Subject comply protocol require followup Add follow condition : Subject symptomatic Subject present &gt; 30 % pulmonary regurgitation fraction define cardiac MRI ≥3+ pulmonary regurgitation echocardiogram Deteriorating RVEF % Progressive tricuspid valve regurgitation ( least moderate degree ) Complicated RVOT obstruction ( RV systolic pressure &gt; 80mmHg ) Persistent arrhythmias Candidates exclude study follow condition present : Existing pulmonary artery branch stenosis artificial pulmonary valve Severe chest wall deformity ADHF Active infection endocarditis require antibiotic therapy Leukopenia ( WBC &lt; 3000mm3 ) Acute chronic anemia ( Hb &lt; 9g/L ) Platelet account &lt; 100,000 cells/mm3 In judgment investigator , percutaneous introduction delivery valve feasible A known hypersensitivity aspirin heparin Positive urine serum pregnancy test female subject Ileofemoral vessel characteristic would preclude safe placement introducer sheath</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Venus P-valve</keyword>
</DOC>